FDA cracks down on ‘misleading’ compounded GLP-1s by telehealth companies

They have basically halted mass compounding of these drugs at the larger 503B facilities. The smaller 503A places are still allowed for now. What happens to people with less money who need these medications to improve their health?

This mostly comes down to a legal point. Approval covers not only the molecule but the exact manufacturing method used to make it. So when the original company produces it in their approved facility it counts as the real thing, while another lab making the same ingredient through a different route does not. If the compounding source uses high-quality material most users would not notice a difference, yet legally it counts as a separate product, similar to how even a high-quality copy is treated differently from the original.

A podcast I heard claimed that pharmaceutical companies own most supplement brands. If true, that could explain why stores selling them face little pressure.

The users over in that compound-focused subreddit seem really worried. I used to feel the same way during the earlier shutdown scare, which is why I ended up here instead of staying anxious about it every day.

It is unfortunate. I would like to share information about alternatives with everyone, but I stay quiet to avoid drawing attention. I only mention it to immediate family.

The agency is proposing to keep these three medications off the allowed bulk list for outsourcing facilities because it sees no clinical need to compound them from bulk ingredients. The original manufacturers did not respond right away to requests for comment. Normally facilities cannot use bulk substances unless the ingredient is on the approved list or the drug is in shortage at every stage of production and dispensing.

This just keeps things as they already are. These drugs are not on the bulk list now, so the current level of concern can stay the same.

Some people are simply making money from middle-aged users who saw mentions online.

I am one of the worried users on that site, which is why I check here regularly. As a senior living on a fixed income I could never afford the brand-name prices. I have a supply of compounded product set aside plus another option in storage. I chose a known source for peace of mind even though it cost more. It is hard to judge other options or decode vague references. It feels wrong that so many people's health depends on one company wanting even higher revenue.

An option coming for people with Medicare Part D coverage is a new demonstration program that may allow continued access at lower cost even for maintenance use.

Those who can pay will not notice. Everyone else losing access will keep supporting processed-food companies and needing more medical care later. It is disappointing.

Exactly. One person's story gets treated as proof that every compounded product or telehealth service is bad. The science on this is not settled at all. I would like to know how that particular case even reached the reporters.